RxDoctor Payments Data
★ My doctorsLook up a doctor →

Paul Sasaura, MD

Orthopaedic Surgery · Carmichael, CANPI 1093717118

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (59.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Smith+Nephew at 35.7% of the total. Among orthopaedic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$232,744in general payments, 2019–2025

Across 284 payments — averaging $819.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$83K
  • Orthalign Inc$77K
  • Medical Device Business Services, Inc.$60K
  • Depuy Synthes Products, Inc.$9K
  • Stryker$2K
  • Johnson & Johnson$999
  • plus $358 from 8 others
$2,300in research payments, 2019–2025

Across 1 payment — averaging $2300.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$2K

What the payments were for

  • Consulting fees$139,36760%
  • Speaking & faculty fees$52,25322%
  • Travel & lodging$32,72214%
  • Food & beverage$8,4024%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew126$83,193
Orthalign Inc54$76,655
Medical Device Business Services, Inc.51$59,929
Depuy Synthes Products, Inc.11$9,470
Stryker22$2,140
Johnson & Johnson9$999
Zimmer Biomet3$189
Heron Therapeutics, Inc.2$45
Aesculap Implant Systems, LLC1$29
Heraeus Medical, LLC.1$27
Acera Surgical, Inc.1$25
BD1$18
Biotissue Holdings Inc.1$13
Ferring Pharmaceuticals Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$232,744 in reported general payments places this provider in the 95th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California →

Medicare billing

Part B allowed, 2024
$517,757
Medicare patients
706
Services billed
3,245

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen200$2,725
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen162$2,543
Ondansetron OdtOndansetron28$406
Celecoxib11$225
Hydromorphone Hcl24$218
Amoxicillin84$153
Clindamycin Hcl23$56
Tramadol Hcl11$25

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Carmichael

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →